A significant shift in U.S. vaccine policy is reshaping how millions of children may access routine immunizations, as several long-standing childhood vaccines are no longer universally recommended but instead placed under a framework known as shared decision-making. The change alters not only clinical practice but also insurance coverage, liability protections,
Leucovorin, a prescription drug traditionally used alongside chemotherapy, has moved from a niche medical role into a highly charged public debate over its potential use in children with autism spectrum disorder. The renewed attention has been driven by regulatory signals, parental advocacy, and small clinical studies, yet the scientific foundation
Heart disease continues to be the leading cause of death, yet recent data indicates a meaningful shift in long-term trends. After years of elevated mortality during the pandemic, deaths linked to cardiovascular disease and stroke have declined, signaling progress driven by improved prevention, earlier diagnosis, and broader public health initiatives.
Understanding how nutritional needs change with age has become a growing focus in health and longevity research, as evidence continues to show that the foods consumed at different life stages can influence disease risk decades later. While a balanced diet remains essential throughout life, the body’s priorities shift as growth,
The process of the United States exiting the World Health Organization has entered a decisive phase, transforming a political announcement into a complex institutional rupture with long-term consequences. What began as a renewed pledge to disengage from multilateral health governance is now exposing legal ambiguities, financial disputes, and strategic risks
Seasoning food has traditionally been associated with flavor, but growing scientific evidence suggests it also plays a critical role in how effectively the body absorbs essential vitamins and micronutrients. Ingredients as common as black pepper and olive oil can transform the nutritional value of everyday meals by improving how nutrients
Novo Nordisk shares moved higher after early U.S. prescription figures signaled a stronger-than-expected market entry for its oral Wegovy obesity treatment, reinforcing investor confidence in the company’s strategy to expand beyond injectable GLP-1 drugs. The launch marks a critical inflection point as demand for obesity therapies continues to accelerate across
Standing on one leg may appear trivial, yet medical research increasingly identifies it as a revealing indicator of how the body and brain age together. What feels automatic in youth gradually becomes more demanding, reflecting subtle changes in muscle integrity, neural processing, and sensory coordination that often develop silently. Unlike
Childhood vaccination coverage in the United States is becoming increasingly uneven, as growing numbers of families opt out of routine immunizations for nonmedical reasons. This shift is reshaping public health risk at the local level, creating clusters of under-vaccinated communities that are more vulnerable to outbreaks of diseases once considered
The fight against cancer in the United States has entered a new phase marked by sustained survival and long-term disease management. Advances in treatment strategies, combined with decades of research investment measured in tens of billions of dollars, have reshaped cancer from a diagnosis once associated with immediate mortality. It
US President Donald Trump has moved to intensify economic pressure on Iran by signing an executive order that threatens additional tariffs on countries that continue commercial ties with Tehran. The measure authorizes penalties on goods entering the United States from any nation deemed to be trading directly or indirectly with
Bad Bunny is preparing for one of the most consequential performances of his career as he steps onto the Super Bowl halftime stage, carrying not only the weight of global stardom but also the responsibility of representing Puerto Rican culture and Latino identity before an audience that regularly surpasses 115
Big Tech shares have come under intense pressure after renewed concerns that aggressive artificial intelligence spending could be outpacing near-term returns. Over the past week, more than $1 trillion in market value has been erased as investors reacted to earnings reports that highlighted the scale and persistence of capital expenditures